636. Myelodysplastic Syndromes: Basic and Translational: Poster I

High dose ascorbate downregulates innate immune cytokines in the bone marrow of TET2 mutant chronic myelomonocytic leukemia

Single cell transcriptomic insights into venetoclax response and resistance in secondary AML evolving from MDS

Machine learning uncovers invariant evolutionary molecular trajectories in MDS

Intermediate and high risk clonal hematopoiesis in germline predisposition families

Neutrophil extracellular traps drive myeloproliferation and immune dysfunction in chronic myelomonocytic leukemia

Single cell transcriptomics reveal long non coding RNA dysregulation in PPP1R15B EIF2A axis impairing erythroid maturation in myelodysplastic syndromes

Characterizing the In Vivo impact of inflammation on Samd9l hematopoietic phenotypes

5 azacytidine treatment reshapes clonal structure and alters mutation dependent splicing in MDS patients